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The signal transducer and activator of transcription (STAT)
family of transcription factors are present in a functionally la-
tent, monomeric form in the cytoplasm of resting cells (D a r -
n e l l, 1997). Following stimulation with cytokines or growth
factors and their binding to a cell-surface receptor, STAT factors
are rapidly tyrosine-phosphorylated, dimerized, and translocat-
ed to the nucleus, where they bind to specific hormone respon-
sive elements of the target genes. There are several members of
the STAT family (STAT1, STAT2, STAT3, STAT4, STAT5, and
STAT6) with different roles in regulating cell growth, prolifera-
tion, and differentiation (M u i, 1999). The liver is a multifunc-
tional organ which emerges from the primitive foregut at day 9
of rat embryonic development (L e m i r e et al., 1991). By the
16th day of gestation, the liver is made up of hepatoblasts
(S h i o j i r i et al., 1991), which differentiate into mature he-
patocytes. Full liver activity is reached around the third week of
postnatal development. Among other functions, the liver plays
an important role during the acute-phase (AP) response, a com-
plex systemic reaction of an organism in response to various
mechanical, chemical, or biological insults (K o j et al., 1982).
As STAT3 and STAT5b were described to be involved in AP re-
sponse regulation in adults, the aim of this work was to deter-
mine their expression throughout rat liver development under
normal and AP conditions.
Male and female albino rats of the Wistar strain were used.
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Fig. 1. Immunoblot analysis of rat liver nuclear extracts with STAT3 (A) and STAT5b (B) antibodies. Proteins (20 μg of proteins were separated by
12% SDS-PAGE, electrotransferred onto PVDF membranes, and incubated with polyclonal rabbit antibody raised against rat STAT3 and STAT5b. The
antigen-antibody complex was visualized by the ECL detection system. Lanes 1 and 2 – 20-day fetal liver; 3 and 4 – 1st postnatal day; 5 and 6 – 3rd
postnatal day; 7 and 8 – 7th postnatal day; 9 and 10 – 14th postnatal day; 11 and 12 – 21st postnatal day; 13 and 14 - 2.5-month-old adult. Lanes 1, 3,







Livers were isolated from: 20-day-old fetuses removed from
10-week-old dams; 1-, 3-, 7-, 14- and 21-day-old neonatals; and
10-week-old adult males. The livers were from up to five litters
of 20-day-old fetuses (i.e., fetuses from up to five dams, de-
pending of the number of the fetuses in each litter) and from 1–,
3-, and 7-day-old neonatals of either the control or the turpen-
tine-treated group. Livers from three neonatals (14- and 21-day-
old animals) and three adult (10-week-old) male rats were
pooled for each group (control and turpentine-treated). The AP
response was induced by a subcutaneous injection of turpentine
oil (1 μl/g of body weight) in the lumbar region of the dams, ne-
onatals, and male adults (B a u m a n n et al., 1984). Ether-an-
esthetized animals were sacrificed 12 h later. Nucleoproteins
were isolated from the liver of control and treated rats accord-
ing to G o r s k i et al. (1986). In order to establish the presence
of STAT3 and STAT5b, nucleoproteins were separated by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) (L a e m m l i,
1970) and analyzed by Western immunoblot assay (T o w b i n
et al., 1979) using polyclonal STAT3 and STAT5b antibodies
(Santa Cruz Biotechnology, USA). 
Immunoblot analysis with STAT3 antibody revealed the
presence of 91 kD and 86 kD STAT3 isoforms throughout liver
development (Fig. 1A). In the fetal liver on the 1st and 7th days
of postnatal development, the relative amounts of both isoforms
were similar (lanes 1, 3, and 5). From the second postnatal
week, the profiles of STAT3 isoforms were similar to those ob-
served in the adult liver, where the amount of the 91 kD isoform
was greater than that of the 86 kD STAT3 isoform (Fig. 1A,
lanes 7, 9, 11, and 13). During the AP response, the 91 kD
STAT3 isoform increased in content, while content of the 86 kD
STAT3 was the same as in the corresponding controls (Fig. 1A,
lanes 2, 4, 6, 8, 10, 12, and 14). As can be seen in Fig. 1B,
STAT5b was detected at all examined time points from the fetal
to the adult liver. The relative concentration of STAT5b was
considerably higher in the fetal liver (lane 1) compared to sam-
ples from postnatal development (lanes 3, 5, 7, 9, and 11) as
well as ones from the adult liver (lane 13). It should be noted
that induction of the AP response did not affect the relative con-
centration of STAT5b in the fetal rat liver (lane 2). However, the
AP response in the postnatal (lanes 4, 6, 8, 10, and 12) and adult
(lane 14) liver was accompanied by decrease in the relative con-
centrations of STAT5b (Fig. 1B). 
Hepatocyte differentiation is still poorly understood be-
cause of its complexity and difficulties of manipulation with the
embryonic liver. Although in the rat it is initiated around day 9
of embryogenesis, hepatocytes continue to proliferate actively
and grow for 2–3 weeks after birth (L e m i r e et al., 1991).
Our results revealed that STAT3 is expressed throuhgout liver
development (Fig. 1A), which points to its role during prolifer-
ation and differentiation of the rat liver. This information is very
important in light of the poorly resolved mechanisms of STAT
protein involvement in cellular proliferation and differentiation.
To date, it was found that STAT3 is an essential regulatory fac-
tor in the early embryonic development of mice (T a k e d a et
al., 1997). As for STAT5, two of its isoforms were described,
i.e., STAT5a (more prominently expressed in the mammary
gland) and STAT5b (the predominant form in the liver)
(S t a n d k e et al., 1994; A k i r a et al., 1994). It is known that
STAT5 is important in growth stimulation and cell differentia-
tion, which is in good correlation with our results showing the
highest level of relative STAT5b concentrations in the fetal liv-
er (Fig. 1B). During acute inflammation, the liver is triggered
by pro-inflammatory cytokines, mainly interleukin (IL)-1 and
IL-6, which in turn provoke up- or down-activation of transcrip-
tion factors that regulate different target genes (R u m i n y et
al., 2001). Moreover, IL-6-directed transcriptional regulation of
target genes in hepatic cells has mostly been correlated with ac-
tivation of the DNA-binding properties of STAT3, which as-
sumes a principal role in its regulation during the AP response
(B o d e et al., 2001; Z h a n g and F u l l e r, 2000). According
to the results presented in this study, STAT3 retains its basic
role, since relative content of the 91 kD STAT3 isoform (deter-
minated as trans-active) was increased during the AP response
at all examined time points (Fig. 1A). However, published data
suggest that STAT5b also takes part in the transcriptional regu-
lation of a prominent AP protein family member, alpha2-macro-
globulin, during the AP response (R i p p e r g e r et al., 1995).
That is in correlation with the results presented in this study,
where the relative concentrations of STAT5b decreased during
postnatal development, but not in the fetal liver (Fig. 1B).
R i p p e r g e r et al. (1995) showed that both STAT3 and
STAT5b were present in rat liver nuclei during the AP response
in vivo, suggesting that both regulatory proteins participate in
the transcriptional induction of AP genes mediated by IL-6 (to
which category the gene for MG belongs).
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